A phase 2 asthma study of Upstream Bio’s TSLP receptor agonist has hit its primary endpoint. But with only the 12-week ...

Current drugs for pancreatic cancer lose effectiveness within months because the tumour becomes resistant. The group from ...

BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.

The U.S. Food and Drug Administration approved Cobenfy on September 26, 2024, making it the first schizophrenia drug with a ...

The gray market is awash with BPC-157, a drug hyped as a cure-all, but unapproved by the FDA. Will RFK Jr. change that?

Step-by-step methods for laying blocks efficiently while keeping accuracy and strength in mind. How can simple techniques speed up construction without cutting corners? Texas Democrat stuns ...

Utrecht University researchers Rodolfo Subert and Marjolein Dijkstra show in their latest study that complex ...

Some say we’ve entered a new age of AI-enabled scientific discovery. But human insight and creativity still can’t be ...

This study provides a useful contribution to understanding how wearable augmentation devices interact with human proprioception, using a longitudinal design over a single session. Results demonstrate ...

Fund announced today a total investment of approximately JPY 1.39 billion (USD 8.8 million1) in six R&D projects for the development of drugs, diagnostics and vaccines for malaria, tuberculosis (TB), ...

Antihypertensive drugs that inhibit the renin–angiotensin system (RAS) have been proposed to have additional benefits beyond their classic effects on the cardiovascular system, including reducing the ...